BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Glycotex Inc. 

140 Wicks Road

North Ryde  New South Wales  2113  Australia
Phone: 61-2-8877-6177 Fax: 61-2-9878-0055


SEARCH JOBS



Segment
Start Up





 Company News
Glycotex Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 6/27/2011 7:59:51 AM    More...
Glycotex Inc. Awarded Cash Grant Under the U.S. Government Qualifying Therapeutic Discovery Program 11/24/2010 6:48:02 AM    More...
Glycotex Inc. Expands Patent Portfolio in Advanced Wound Healing Indications 2/11/2010 10:20:39 AM    More...
Glycotex Inc.'s Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 4/7/2009 9:02:42 AM    More...
Glycotex Inc. Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing 10/21/2008 8:45:21 AM    More...
Glycotex Inc. Finalizes Collaboration Agreement with Advanced Medical Solutions Group plc (AMS) 10/17/2008 11:44:48 AM    More...
Glycotex Inc. Completes Enrollment in Phase IIa Study of Lead Product Candidate GLYC-101 for Wound Healing 3/13/2008 8:26:11 AM    More...
Glycotex Inc. Receives $0.5 Million From Second Tranche of Private Share Placement 1/16/2008 8:52:58 AM    More...
Glycotex Inc. Obtains Active IND From US FDA for GLYC-101 Wound Healing Compound 1/8/2008 9:55:49 AM    More...
Novogen Limited (NVGN) Subsidiary Glycotex Inc. Receives Additional Funding 2/27/2007 2:38:35 PM    More...
12

//-->